BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paudyal B, Oriuchi N, Paudyal P, Higuchi T, Nakajima T, Endo K. Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography. Cancer Sci. 2008;99:260-266. [PMID: 18271924 DOI: 10.1111/j.1349-7006.2007.00683.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Furukawa H, Ikuma H, Asakura K, Uesaka K. Prognostic importance of standardized uptake value on F-18 fluorodeoxyglucose-positron emission tomography in biliary tract carcinoma. J Surg Oncol. 2009;100:494-499. [PMID: 19653260 DOI: 10.1002/jso.21356] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
2 Hong R, Lim SC. 18F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma. World J Gastroenterol 2012; 18(2): 168-174 [PMID: 22253523 DOI: 10.3748/wjg.v18.i2.168] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
3 Xiao T, Kurita H, Shimane T, Nakanishi Y, Koike T. Vital staining with iodine solution in oral cancer: iodine infiltration, cell proliferation, and glucose transporter 1. Int J Clin Oncol 2013;18:792-800. [DOI: 10.1007/s10147-012-0450-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
4 Yamada T, Uchida M, Kwang-lee K, Kitamura N, Yoshimura T, Sasabe E, Yamamoto T. Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2012;113:464-71. [DOI: 10.1016/j.tripleo.2011.04.006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
5 Chen J, Zhang S, Li Y, Tang Z, Kong W. Hexokinase 2 overexpression promotes the proliferation and survival of laryngeal squamous cell carcinoma. Tumour Biol 2014;35:3743-53. [PMID: 24363061 DOI: 10.1007/s13277-013-1496-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 5.5] [Reference Citation Analysis]
6 Kubo Y, Aishima S, Tanaka Y, Shindo K, Mizuuchi Y, Abe K, Shirabe K, Maehara Y, Honda H, Oda Y. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma. Human Pathology 2014;45:1610-7. [DOI: 10.1016/j.humpath.2014.03.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
7 Yoon SO, Jeon TJ, Park JS, Ryu YH, Lee JH, Yoo JS, Kim JK, Yoon DS, Oh EJ. Analysis of the roles of glucose transporter 1 and hexokinase 2 in the metabolism of glucose by extrahepatic bile duct cancer cells. Clin Nucl Med 2015;40:e178-82. [PMID: 25608150 DOI: 10.1097/RLU.0000000000000640] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
8 Tsukada H, Muramatsu T, Miyazawa M, Iida T, Ikeda M, Shida M, Hirasawa T, Kajiwara H, Murakami M, Yasuda M, Mikami M. Long Term Prognostic Implications of Expression of Glucose Transporter-1 and Hexokinase II in Patients with Stage I Uterine Leiomyosarcoma. Acta Histochem Cytochem 2012;45:147-54. [PMID: 22685357 DOI: 10.1267/ahc.11063] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
9 Takenaka T, Yano T, Ito K, Morodomi Y, Miura N, Kawano D, Shoji F, Abe K, Honda H, Maehara Y. Biological significance of the maximum standardized uptake values on positron emission tomography in non-small cell lung cancer: Biological Significance on PET in NSCLC. J Surg Oncol 2009;100:688-92. [DOI: 10.1002/jso.21386] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
10 Yamamoto M, Inohara H, Nakagawa T. Targeting metabolic pathways for head and neck cancers therapeutics. Cancer Metastasis Rev 2017;36:503-14. [PMID: 28819926 DOI: 10.1007/s10555-017-9691-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
11 Choi BH, Song HS, An YS, Han SU, Kim JH, Yoon JK. Relation between fluorodeoxyglucose uptake and glucose transporter-1 expression in gastric signet ring cell carcinoma. Nucl Med Mol Imaging 2011;45:30-5. [PMID: 24899975 DOI: 10.1007/s13139-010-0058-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
12 Moreno-Sánchez R, Rodríguez-Enríquez S, Saavedra E, Marín-Hernández A, Gallardo-Pérez JC. The bioenergetics of cancer: is glycolysis the main ATP supplier in all tumor cells? Biofactors 2009;35:209-25. [PMID: 19449450 DOI: 10.1002/biof.31] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 7.3] [Reference Citation Analysis]
13 Yang H, Zhong JT, Zhou SH, Han HM. Roles of GLUT-1 and HK-II expression in the biological behavior of head and neck cancer. Oncotarget 2019;10:3066-83. [PMID: 31105886 DOI: 10.18632/oncotarget.24684] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
14 Alvarez JV, Belka GK, Pan TC, Chen CC, Blankemeyer E, Alavi A, Karp JS, Chodosh LA. Oncogene pathway activation in mammary tumors dictates FDG-PET uptake. Cancer Res. 2014;74:7583-7598. [PMID: 25239452 DOI: 10.1158/0008-5472.can-14-1235] [Cited by in Crossref: 47] [Cited by in F6Publishing: 27] [Article Influence: 6.7] [Reference Citation Analysis]
15 Suzuki H, Komuta M, Bolog A, Yokobori T, Wada S, Araki K, Kubo N, Watanabe A, Tsukagoshi M, Kuwano H. Relationship between 18-F-fluoro-deoxy-d-glucose uptake and expression of glucose transporter 1 and pyruvate kinase M2 in intrahepatic cholangiocarcinoma. Digestive and Liver Disease 2015;47:590-6. [DOI: 10.1016/j.dld.2015.03.017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
16 Tong S, Lee J, Ki K, Choi Y, Seol H, Lee S, Huh C, Kim G, Lim S. Correlation Between FDG Uptake by PET/CT and the Expressions of Glucose Transporter Type 1 and Hexokinase II in Cervical Cancer: . International Journal of Gynecological Cancer 2012;22:654-8. [DOI: 10.1097/igc.0b013e31824864e6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
17 Lan BY, Kwee SA, Wong LL. Positron emission tomography in hepatobiliary and pancreatic malignancies: a review. Am J Surg. 2012;204:232-241. [PMID: 22464445 DOI: 10.1016/j.amjsurg.2011.07.025] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
18 Palmieri D, Fitzgerald D, Shreeve SM, Hua E, Bronder JL, Weil RJ, Davis S, Stark AM, Merino MJ, Kurek R, Mehdorn HM, Davis G, Steinberg SM, Meltzer PS, Aldape K, Steeg PS. Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis. Mol Cancer Res 2009;7:1438-45. [PMID: 19723875 DOI: 10.1158/1541-7786.MCR-09-0234] [Cited by in Crossref: 139] [Cited by in F6Publishing: 95] [Article Influence: 11.6] [Reference Citation Analysis]
19 Amann T, Hellerbrand C. GLUT1 as a therapeutic target in hepatocellular carcinoma. Expert Opin Ther Targets 2009;13:1411-27. [PMID: 19874261 DOI: 10.1517/14728220903307509] [Cited by in Crossref: 118] [Cited by in F6Publishing: 119] [Article Influence: 10.7] [Reference Citation Analysis]
20 Mukada N, Tosaka M, Matsumura N, Yamaguchi R, Aihara M, Isoda K, Higuchi T, Tsushima Y, Yokoo H, Yoshimoto Y. Subtype-dependent difference of glucose transporter 1 and hexokinase II expression in craniopharyngioma: an immunohistochemical study. Sci Rep 2021;11:126. [PMID: 33420213 DOI: 10.1038/s41598-020-80259-4] [Reference Citation Analysis]
21 Botzer LE, Maman S, Sagi-Assif O, Meshel T, Nevo I, Yron I, Witz IP. Hexokinase 2 is a determinant of neuroblastoma metastasis. Br J Cancer 2016;114:759-66. [PMID: 26986252 DOI: 10.1038/bjc.2016.26] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 7.6] [Reference Citation Analysis]
22 Sungwan P, Lert-Itthiporn W, Silsirivanit A, Klinhom-On N, Okada S, Wongkham S, Seubwai W. Bioinformatics analysis identified CDC20 as a potential drug target for cholangiocarcinoma. PeerJ 2021;9:e11067. [PMID: 33777535 DOI: 10.7717/peerj.11067] [Reference Citation Analysis]
23 Nakajo M, Kajiya Y, Tani A, Yoneda S, Shirahama H, Higashi M, Nakajo M. 18FDG PET for grading malignancy in thymic epithelial tumors: Significant differences in 18FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: Preliminary study. European Journal of Radiology 2012;81:146-51. [DOI: 10.1016/j.ejrad.2010.08.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
24 Suh DH, Kim MA, Kim H, Kim M, Kim HS, Chung HH, Kim Y, Song YS. Association of overexpression of hexokinase II with chemoresistance in epithelial ovarian cancer. Clin Exp Med 2014;14:345-53. [DOI: 10.1007/s10238-013-0250-9] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 6.8] [Reference Citation Analysis]
25 Strobel K, Bode B, Dummer R, Veit-haibach P, Fischer DR, Imhof L, Goldinger S, Steinert HC, von Schulthess GK. Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma. Eur J Nucl Med Mol Imaging 2009;36:1774-82. [DOI: 10.1007/s00259-009-1175-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
26 Wang J, Shao Y, Liu B, Wang X, Geist BK, Li X, Li F, Zhao H, Hacker M, Ding H, Zhang H, Huo L. Dynamic 18F-FDG PET imaging of liver lesions: evaluation of a two-tissue compartment model with dual blood input function. BMC Med Imaging 2021;21:90. [PMID: 34034664 DOI: 10.1186/s12880-021-00623-2] [Reference Citation Analysis]
27 Thamrongwaranggoon U, Seubwai W, Phoomak C, Sangkhamanon S, Cha'on U, Boonmars T, Wongkham S. Targeting hexokinase II as a possible therapy for cholangiocarcinoma. Biochem Biophys Res Commun 2017;484:409-15. [PMID: 28131825 DOI: 10.1016/j.bbrc.2017.01.139] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
28 Feng W, Gentles A, Nair RV, Huang M, Lin Y, Lee CY, Cai S, Scheeren FA, Kuo AH, Diehn M. Targeting unique metabolic properties of breast tumor initiating cells. Stem Cells 2014;32:1734-45. [PMID: 24497069 DOI: 10.1002/stem.1662] [Cited by in Crossref: 74] [Cited by in F6Publishing: 73] [Article Influence: 12.3] [Reference Citation Analysis]
29 Daskalow K, Pfander D, Weichert W, Rohwer N, Thelen A, Neuhaus P, Jonas S, Wiedenmann B, Benckert C, Cramer T. Distinct temporospatial expression patterns of glycolysis-related proteins in human hepatocellular carcinoma. Histochem Cell Biol. 2009;132:21-31. [PMID: 19350262 DOI: 10.1007/s00418-009-0590-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
30 Park SG, Lee JH, Lee WA, Han KM. Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma. Nuclear Medicine and Biology 2012;39:1167-72. [DOI: 10.1016/j.nucmedbio.2012.07.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
31 Shim HK, Lee WW, Park SY, Kim H, So Y, Kim SE. Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas. Nuclear Medicine and Biology 2009;36:191-7. [DOI: 10.1016/j.nucmedbio.2008.11.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
32 Zhang MX, Hua YJ, Wang HY, Zhou L, Mai HQ, Guo X, Zhao C, Huang WL, Hong MH, Chen MY. Long-term prognostic implications and therapeutic target role of hexokinase II in patients with nasopharyngeal carcinoma. Oncotarget 2016;7:21287-97. [PMID: 26848773 DOI: 10.18632/oncotarget.7116] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
33 Hoshi M, Takada J, Oebisu N, Hata K, Ieguchi M, Nakamura H. Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT. Arch Orthop Trauma Surg 2012;132:1561-8. [PMID: 22825642 DOI: 10.1007/s00402-012-1588-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
34 Daniel Y, Lelou E, Aninat C, Corlu A, Cabillic F. Interplay between Metabolism Reprogramming and Epithelial-to-Mesenchymal Transition in Cancer Stem Cells. Cancers (Basel) 2021;13:1973. [PMID: 33923958 DOI: 10.3390/cancers13081973] [Reference Citation Analysis]
35 Kozaka K, Kobayashi S, Takamura H, Sato Y, Kitao A, Inoue D, Yoneda N, Tajima H, Kinuya S, Harada K, Ohta T, Koda W, Matsui O, Gabata T. Differences in 18F-FDG Uptake and Expression of Glucose Transporter Between 2 Distinct Subtypes of Mass-Forming Intrahepatic Cholangiocarcinomas. Clin Nucl Med 2020;45:e267-73. [PMID: 32366791 DOI: 10.1097/RLU.0000000000003055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
36 Ikeno Y, Seo S, Iwaisako K, Yoh T, Nakamoto Y, Fuji H, Taura K, Okajima H, Kaido T, Sakaguchi S, Uemoto S. Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis. J Transl Med. 2018;16:95. [PMID: 29642912 DOI: 10.1186/s12967-018-1475-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
37 Chen X, Gao Y, Li D, Cao Y, Hao B. LncRNA-TP53TG1 Participated in the Stress Response Under Glucose Deprivation in Glioma. J Cell Biochem 2017;118:4897-904. [PMID: 28569381 DOI: 10.1002/jcb.26175] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]